Clinical Trials Logo

Clinical Trial Summary

Differentiation between non-muscle-invasive bladder cancer (NMIBC) and muscle-invasive bladder cancer (MIBC) is a cornerstone in the treatment plans.Therefore, this study will try to evaluate the sensitivity and reliability of mpMRI in accurate diagnosis of cancer bladder. Primary objective: to detect the sensitivity of multiparametric MRI in differentiation between muscle Invasive and non-muscle invasive Urinary Bladder Cancer in relation to the conventional cystoscopy and histopathological examination of the biopsy.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05324033
Study type Observational
Source Helwan University
Contact
Status Completed
Phase
Start date May 1, 2022
Completion date April 1, 2023

See also
  Status Clinical Trial Phase
Recruiting NCT03301493 - Genomic Testing and Resulting Medical Decisions
Completed NCT05278598 - 3 Ultrasound Guided Plane Blocks for Perioperative Analgesia in Patients Undergoing Radical Cystectomy N/A
Recruiting NCT03896958 - The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)
Not yet recruiting NCT05262166 - Opioid Free Anesthesia in Prolonged Surgery N/A
Completed NCT05822518 - Outcome of Perioperative Immune Enhancing Nutrition in Patients Undergoing Radical Cystectomy N/A